Co-Diagnostics (CODX +35.7%) jumps on more than a 7x surge in volume in response to its announcement of
sales of its newly developed test for 2019-nCoV, the coronavirus
causing the current outbreak, still largely confined to China. It says
the order calls for the delivery of tests for various international
markets and, most importantly, included payment for the initial shipment
of product.
https://seekingalpha.com/news/3540187-co-diagnostics-up-36-on-coronavirus-test-sales
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.